Biotest Aktiengesellschaft Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, sales was EUR 275.3 million compared to EUR 253.1 million a year ago. Net income was EUR 1.7 million compared to net loss of EUR 19.9 million a year ago. Basic earnings per share from continuing operations was EUR 0.03 compared to basic loss per share from continuing operations of EUR 0.5 a year ago.